Elisa Sensi Selected Research

Transforming Growth Factors (Transforming Growth Factor)

5/2016

Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Sensi Research Topics

Disease

10	Neoplasms (Cancer) 06/2021 - 11/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 09/2010
2	Adenocarcinoma of Lung 01/2019 - 10/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2017 - 04/2015
2	Papillary Thyroid Cancer 05/2016 - 09/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 06/2014
2	Breast Neoplasms (Breast Cancer) 12/2010 - 10/2006
1	Proctitis 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Disease Progression 01/2019
1	Hand-Foot Syndrome 01/2019
1	Anaplastic Thyroid Carcinoma 01/2019
1	Malignant Mesothelioma 01/2017
1	Mesothelioma 01/2017
1	Lymphadenopathy 01/2017
1	Carcinogenesis 01/2017
1	Adenoma (Adenomas) 05/2016
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Lymphoma (Lymphomas) 11/2014
1	Sarcoma (Soft Tissue Sarcoma) 05/2014
1	Febrile Neutropenia 09/2010
1	Hypertension (High Blood Pressure) 09/2010
1	Lymphatic Metastasis 09/2010
1	Dehydration (Water Stress) 09/2010
1	Stomatitis 09/2010

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 01/2019 - 09/2010
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 09/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 09/2010
3	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 09/2010
2	ParaffinIBA 06/2021 - 04/2015
2	Formaldehyde (Formol)FDA Link 06/2021 - 04/2015
2	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2019
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 04/2015
2	Monoclonal AntibodiesIBA 04/2015 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 11/2003
2	Biomarkers (Surrogate Marker)IBA 09/2014 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 05/2014
2	LigandsIBA 09/2014 - 01/2012
1	prolinedithiocarbamate (PDTC)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	crenolanibIBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	MitogensIBA 01/2017
1	trametinibIBA 01/2017
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	CateninsIBA 05/2016
1	Connective Tissue Growth FactorIBA 05/2016
1	Metalloproteases (Metalloproteinases)IBA 05/2016
1	L-SelectinIBA 05/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2016
1	IntegrinsIBA 05/2016
1	OsteopontinIBA 05/2016
1	ThrombospondinsIBA 05/2016
1	CollagenIBA 05/2016
1	Laminin (Merosin)IBA 05/2016
1	Cadherins (E-Cadherin)IBA 05/2016
1	Fibronectins (Fibronectin)IBA 05/2016
1	Lysine (L-Lysine)FDA Link 11/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2015
1	Histones (Histone)IBA 11/2015
1	Leucovorin (Folinic Acid)FDA Link 10/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	CrizotinibIBA 11/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2014
1	PlatinumIBA 10/2014
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2014
1	Cetuximab (Erbitux)FDA Link 09/2014
1	Anaplastic Lymphoma KinaseIBA 06/2014
1	CarbonIBA 04/2014
1	Chemokine ReceptorsIBA 01/2012
1	Codon (Codons)IBA 12/2010
1	Capsules (Microcapsules)IBA 09/2010
1	imidazole mustard (BIC)IBA 10/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 10/2014
2	Therapeutics 01/2019 - 05/2014
1	Neoadjuvant Therapy 01/2019
1	Chemoradiotherapy 01/2019
1	Salvage Therapy 10/2014